View in EDS

75PCemiplimab, a human PD-1 monoclonal antibody, in patients (pts) with recurrent or metastatic cervical cancer: Interim data from phase I cohorts.

Saved in:
Bibliographic Details
Title: 75PCemiplimab, a human PD-1 monoclonal antibody, in patients (pts) with recurrent or metastatic cervical cancer: Interim data from phase I cohorts.
Authors: Rischin, D1 (AUTHOR), Gil-Martin, M2 (AUTHOR), González-Martin, A3 (AUTHOR), Brana, I4 (AUTHOR), Hou, J Y5 (AUTHOR), Cho, D6 (AUTHOR), Falchook, G7 (AUTHOR), Formenti, S8 (AUTHOR), Jabbour, S9 (AUTHOR), Moore, K10 (AUTHOR), Naing, A11 (AUTHOR), Papadopoulos, K P12 (AUTHOR), Baranda, J13 (AUTHOR), Weise, A14 (AUTHOR), Fury, M G15 (AUTHOR), Feng, M16 (AUTHOR), Li, J17 (AUTHOR), Lowy, I15 (AUTHOR), Mathias, M15 (AUTHOR)
Source: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdy487.006